Dr Reddy’s delays semaglutide supplies due to API issue
MUMBAI: Dr Reddy’s Laboratories’ plans to capitalize on the early generic semaglutide market have hit a setback after manufacturing issues delayed supplies of the blockbuster diabetes and weight-loss drug, forcing…
Dr Reddy’s gets EC nod for AVT03: New Prolia and Xgeva biosimilar set to launch across Europe
Dr Reddy’s Laboratories has received marketing approval from the European Commission (EC) for AVT03, a biosimilar of Prolia (denosumab) and Xgeva (denosumab) prescribed in the treatment of bone related conditions,…
LABORATORY ACCREDITATION: How achieved? – Process of Accreditation
There are FOUR distinct stages for accreditation process as explained below. Stage I • Prepare your laboratory’s application for NABL accreditation, giving all desired information and enlisting the test(s) along…
